Corporate News     06-Aug-20
Unichem Laboratories receives ANDA approval for Tolterodine Tartrate Tablets
Unichem Laboratories announced that it has received ANDA approval for its Tolterodine Tartrate Tablets, USP 1 mg and 2 mg from the United States Food and Drug Administration (USFDA) to market a generic version of DETROL® (tolterodine tartrate) tablets of Pfizer Inc.

Tolterodine tartrate tablets are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. The product will be commercialized from Unichem's Goa Plant.

Previous News
  Unichem Laboratories reports consolidated net loss of Rs 44.27 crore in the March 2023 quarter
 ( Results - Announcements 23-May-23   14:42 )
  Sun Pharmaceuticals Industries Ltd Falls 1.71%
 ( Hot Pursuit - 20-Jun-24   09:30 )
  Unichem Laboratories receives downgrade in LT credit ratings
 ( Corporate News - 19-Sep-22   16:27 )
  Board of Unichem Laboratories appoints director
 ( Corporate News - 20-Mar-23   11:16 )
  Unichem Lab corrects on profit selling
 ( Hot Pursuit - 10-Dec-21   11:40 )
  Unichem Laboratories to convene board meeting
 ( Corporate News - 28-Jan-23   12:58 )
  Unichem Laboratories reports consolidated net loss of Rs 6.19 crore in the June 2019 quarter
 ( Results - Announcements 29-Jul-19   10:10 )
  Unichem Laboratories Ltd leads losers in 'A' group
 ( Hot Pursuit - 02-Dec-22   15:00 )
  Unichem Laboratories receives USFDA approval for Doxazosin tablets
 ( Corporate News - 11-Jan-24   12:04 )
  Unichem Laboratories reports consolidated net loss of Rs 17.19 crore in the March 2020 quarter
 ( Results - Announcements 19-Jun-20   14:23 )
  Unichem Laboratories reports consolidated net loss of Rs 11.49 crore in the June 2021 quarter
 ( Results - Announcements 31-Jul-21   15:01 )
Other Stories
  Tinna Trade raises Rs 49 cr to fund its growth plans
  06-Jul-24   11:10
  Integra Essentia announces merger with G G Engineering
  06-Jul-24   11:05
  Ugro Capital to raise Rs 75 cr via NCD issuance
  06-Jul-24   10:58
  Board of D.P. Abhushan approves preferential allotment of shares and warrants
  06-Jul-24   10:50
  Life Insurance Corporation of India invest Rs 14 cr in Sri Lankan subsidiary
  06-Jul-24   10:49
  High Energy Batteries (India) to discuss results
  06-Jul-24   10:29
  Havells India schedules board meeting
  06-Jul-24   10:29
  Axis Bank announces board meeting date
  06-Jul-24   10:29
  Mastek to conduct board meeting
  06-Jul-24   10:29
  Oriental Hotels to conduct board meeting
  06-Jul-24   10:29
Back Top